GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers
نویسندگان
چکیده
Eric M. Reiman,* Jennifer A. Webster, Amanda J. Myers, John Hardy, Travis Dunckley, Victoria L. Zismann, Keta D. Joshipura, John V. Pearson, Diane Hu-Lince, Matthew J. Huentelman, David W. Craig, Keith D. Coon, Winnie S. Liang, RiLee H. Herbert, Thomas Beach, Kristen C. Rohrer, Alice S. Zhao, Doris Leung, Leslie Bryden, Lauren Marlowe, Mona Kaleem, Diego Mastroeni, Andrew Grover, Christopher B. Heward, Rivka Ravid, Joseph Rogers, Michael L. Hutton, Stacey Melquist, Ron C. Petersen, Gene E. Alexander, Richard J. Caselli, Walter Kukull, Andreas Papassotiropoulos, and Dietrich A. Stephan* Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA Banner Alzheimer’s Institute, Phoenix, AZ 85006, USA Department of Psychiatry, University of Arizona, Tucson, AZ 85724, USA Department of Psychiatry and Behavioral Sciences, University of Miami, Miller School of Medicine, Miami, FL 33136, USA Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, 20892, USA Reta Lila Weston Laboratories, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N, 3BG, England Division of Thoracic Oncology Research, St. Joseph’s Hospital, Phoenix, AZ 85013, USA Sun Health Research Institute, Sun City, AZ 85351, USA Kronos Science Laboratory, Phoenix, AZ 85016, USA Netherlands Institute for Neurosciences, Dutch Royal Academy of Arts and Sciences, Meibergdreef 47 AB Amsterdam, The Netherlands Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA Department of Psychology, Arizona State University, Tempe, AZ 85281, USA Department of Neurology, Mayo Clinic, Scottsdale, AZ 85259, USA Division of Molecular Psychology and Life Sciences Training Facility, Biozentrum, University of Basel, Switzerland National Alzheimer’s Coordinating Center, Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98195, USA Arizona Alzheimer’s Consortium, Phoenix AZ 85006, USA These authors contributed equally to this work. *Correspondence: [email protected] (E.M.R.), [email protected] (D.A.S.) DOI 10.1016/j.neuron.2007.05.022
منابع مشابه
Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer’s Disease
Early detection of Alzheimer's disease (AD) has been challenging as current biomarkers are invasive and costly. Strong predictors of future AD diagnosis include lower volume of the hippocampus and entorhinal cortex, as well as the ɛ4 allele of the Apolipoprotein E gene (APOE) gene. Therefore, studying functions that are critically mediated by the hippocampus and entorhinal cortex, such as spati...
متن کاملAPOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
BACKGROUND Previous studies have investigated associations between apolipoprotein E (APOE)-ɛ4 allele status and acetylcholinesterase inhibitor treatment response in patients with Alzheimer's disease. The ability to draw definitive conclusions regarding the effect of APOE-ɛ4 genotype on treatment response has been hindered by inconsistent results among studies and methodological limitations that...
متن کاملReduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele.
Apolipoprotein (APOE) ɛ4-related differences in memory performance have been detected before age 65. The hippocampus and the surrounding medial temporal lobe (MTL) structures are the first site affected by Alzheimer's disease (AD) and the MTL is the seat of episodic memory, including visuo-spatial memory. While reports of APOE ɛ4-related differences in these brain structures are not consistent ...
متن کاملPrecuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.
Neurodegenerative diseases such as Alzheimer's disease (AD) have been recognized to exhibit disease-specific brain vulnerability patterns. Apolipoprotein E (APOE) ɛ4 allele imparts a high genetic risk of developing AD. Whether the APOE ɛ4 allele damages the brain when cognitive functions are still intact is important to understand, especially for possible early detection and intervention. This ...
متن کاملThe GAB2 and BDNF polymorphisms and the risk for late-onset Alzheimer's disease in an elderly Brazilian sample--ERRATUM.
BACKGROUND Evidences suggest that GAB2 and BDNF genes may be associated with Alzheimer's disease (AD). We aimed to investigate the GAB2 rs2373115 and BDNF rs6265 polymorphisms and the risk of AD in a Brazilian sample. METHODS 269 AD patients and 114 controls were genotyped with Real-time PCR. Multifactor dimensionality reduction (MDR) was employed to explore the effects of gene-gene interacti...
متن کاملA Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease
The apolipoprotein E (APOE) gene has been consistently shown to modulate the risk of Alzheimer's disease (AD). Here, using an AD and normal aging dataset primarily consisting of three AD multi-center studies (n = 1,781), we compared the effect of APOE and amyloid-β (Aβ) on baseline hippocampal volumes in AD patients, mild cognitive impairment (MCI) subjects, and healthy controls. A large sample...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Neuron
دوره 54 شماره
صفحات -
تاریخ انتشار 2007